A new technology has been tested for the first time on people which can give a 3-D image of the patient’s arteries and better treat heart diseases. The technology is in the early stages of testing according to a feasibility study published in Circulation: Cardiovascular Interventions, an American Heart Association journal. According to the cardiologists this is a very exciting technology that holds great promise. The study allows doctors to assess more accurately and rapidly the length, branching pattern and angles of heart arteries, as well as any blockages. Cardiologists currently use two-dimensional X-ray images shot from different angles to visualize arteries inside the body. They also inject contrast dye into a thin tube — a catheter — inserted into a patient’s leg artery and threaded up to the heart to produce shadow images during a cardiac catheterization procedure. Although it uses existing X-ray systems, the new software reduces the need for several of the images, thus reducing patients’ exposure to radiation and contrast dye while also decreasing the time doctors need to analyze the images. The comparison of 2-D and 3-D computer images of the coronary artery systems will be tested in multiple centres around the world. It will be formally tested to see the impact on clinical care. Cardiovascular disease is the number one killer in the United States. According to the World Health Organisation, it is responsible for 17 million deaths worldwide. Be a part of Elets Collaborative Initiatives. Join Us for
Upcoming Events and explore business opportunities. Like us on
Facebook , connect with us on
LinkedIn and follow us on
Twitter ,
Instagram. "Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Related Research
P&G Health and IMA Unveil India’s First Evidence-Based Patient Recovery Guidelines Focused on Micronutrients
Strengthening post-illness care in India, Procter & Gamble Health Limited has partnered with the Indian Medical Asso...
30 Years of Scientific Rigour: DiagnoSearch Reinforces Its Role in Accelerating Pharma Pipelines
DiagnoSearch Life Sciences, one of India’s longest-standing and most trusted Clinical Research Organisations (CROs), h...
Servier India Partners with MedGenome & Strand Life Sciences, Expanding AML & CCA Testing
To advance India's precision oncology and equitable access to molecular diagnostics, Servier India, a subsidiary of the ...
One in Four Indians at Risk of Heart Disease as Lipid Imbalances Rise Across Age Groups: Metropolis Study | World Heart Day Special
Metropolis Healthcare Limited, one of India’s largest and most respected pathology networks, has released a nationwide...
IIT Roorkee Scientists Unveil Novel Drug Candidate to Tackle Antibiotic Resistance Crisis
Scientists at the Indian Institute of Technology (IIT) Roorkee have identified a potential drug candidate capable of res...
82% Prefer Diagnostic Centres Over Hospitals in India: ekincare Report
A new data-backed report by ekincare uncovers a decisive change in India’s preventive healthcare landscape, placing di...
Axiom-4 to Test First FDA-Approved Cancer Drug in Space, Pioneering Microgravity-Driven Oncology Research
In a landmark development for pharmaceutical research, the upcoming Axiom-4 (Ax-4) mission is set to test Rebecsinib, th...
Indian Life Sciences Sector Pioneers Future-Ready Lab Design, Setting Global Benchmark: Unispace Survey
A new global survey by Unispace, a leader in workplace strategy, design, and construction, reveals that India's life sci...
Govt Funds ₹330 Cr AI-Healthcare CoE by IIT Delhi & AIIMS Under ‘Make AI Work for India’ Initiative
The Indian Institute of Technology (IIT) Delhi and the All India Institute of Medical Sciences (AIIMS) Delhi have signed...
Vgenomics & Dr. Shroff’s Eye Hospital Unveil Tear-Based Diagnostic Breakthrough Using AI-Powered RgenX-LENS Platform
Vgenomics, a cutting-edge genomics company headquartered in Delhi, has entered an exclusive partnership with Dr. Shroff...
